HIF1A and cancer: Metformin has made an indelible contribution to reducing mortality and prolonging survival in many cancers and the possible mechanism by which metformin exerts its anticancer effect may involve interference with mitochondrial ETC complex I activity and HIF-1 expression (Wheaton et al., 2014).